"Mediclinic Bloemfontein, the biggest hospital in the Mediclinic private hospital group opened its doors in July 1990. Since its inception the hospital has been a huge success due to its carefully planned design, sophisticated equipment and facilities, its professional and dedicated staff and management and leading medical professionals. Mediclinic Bloemfontein is well known as the preferred super speciality hospital in central South Africa. The double-storey integrated cardiac unit opened in 2000, connecting the two heart catheterisation laboratories and two heart theatres with critical care units by means of an air bridge. The full time, experienced cardiologists and cardiothoracic surgeons have a reputation of excellence."

During the past decade, Bloemfontein Medi-Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bloemfontein Medi-Clinic" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Bloemfontein Medi-Clinic" are "Cerebrovascular Accident" (1 trials), "Coronary Arteriosclerosis" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Artery Restenosis" (1 trials) and "Coronary Artery Stenosis" (1 trials). Many other conditions were trialed in "Bloemfontein Medi-Clinic" in a lesser frequency.

Most popular intervention types in "Bloemfontein Medi-Clinic" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Implantable Defibrillator" (1 trials), "XIENCE V®/ XIENCE PRIME™" (1 trials) and "YM872 (zonampanel)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bloemfontein Medi-Clinic" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Bloemfontein Medi-Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Bloemfontein Medi-Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bloemfontein Medi-Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".